# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4720019 | Binding | Inhibition of BCR (unknown origin)/recombinant human N-terminal His-tagged ABL1 (27 to end residues) expressed in baculovirus infected Sf9 cells using ABLtide as substrate preincubated for 30 mins followed by substrate addition and measured after 1 hr in presence of ATP by kinase-Glo luminescence assay | Homo sapiens | 15 | ALA4715809 | cell-based format | Scientific Literature | |
2. | ALA4720020 | Functional | Antiproliferative activity against human K562 cells assessed as reduction in cell viability after 24 hrs by CCK8 assay | Homo sapiens | 11 | ALA4715809 | cell-based format | Scientific Literature | |
3. | ALA4720021 | Functional | Antiproliferative activity against human U937 cells assessed as reduction in cell viability after 24 hrs by CCK8 assay | Homo sapiens | 11 | ALA4715809 | cell-based format | Scientific Literature | |
4. | ALA4720022 | ADME | Cytotoxicity against human 293T cells assessed as reduction in cell viability after 24 hrs by CCK8 assay | Homo sapiens | 11 | ALA4715809 | cell-based format | Scientific Literature | |
5. | ALA4720023 | Binding | Potency index, ratio of staurosporine IC50 to test compound IC50 for inhibition of BCR (unknown origin)/recombinant human N-terminal His-tagged ABL1 (27 to end residues) expressed in baculovirus infected Sf9 cells using ABLtide as substrate preincubated for 30 mins followed by substrate addition and measured after 1 hr in presence of ATP by kinase-Glo luminescence assay | Homo sapiens | 1 | ALA4715809 | cell-based format | Scientific Literature |